The Evolution of Mental Health & Neuroscience
PSYCHEDELIC SCIENCE INSTITUTE
About PSI
Psychedelic Science Institute (PSI) with support from the Psychedelic Innovation Fund (PIF) is devoted to the application of psychedelic-assisted therapies (PAT) for mental health and neurocognitive disorders, and for exploring how psychedelics as neuroplastogens can optimize behavior, brain health, and quality of life.
Our mission is:
To be a leading global institute conducting clinical trials of psychedelic medicines.
To be an innovator in creating psychedelic-based care models and clinics that are affordable, sustainable and scalable.
To offer education and training in psychedelic medicine and science.
To expand access to psychedelic-based therapies to underserved populations.
Creating the future of mental health care. Advancing the neurosciences through psychedelic-assisted therapy and research.
Founders
Keith Heinzerling, MD
Karina Sergi, MS, MFT
Micah Linton, PsyD
Daniel Kelly, MD
Contact Us
Interested in working together? Fill out some information and we will be in touch shortly.